Search research articles
Contact Us
Filters
Showing results (81-90 of 144) with videos related to
Page
of 15
Sort By:
Leukemia
|
February 16, 2022
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
Nicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, et al.
Annals of Hematology
|
April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients
Verónica González-Calle, Abigail Slack, Niamh Keane, et al.
Blood Cancer Journal
|
February 5, 2025
Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
Rodrigo Fonseca, Yuan Xiao Zhu, Laura A Bruins, et al.
Blood
|
July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes
K Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Cancers
|
July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations
J Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Leukemia
|
March 16, 2019
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Blood
|
August 15, 2022
Progression and survival of MBL: a screening study of 10 139 individuals
Susan L Slager, Sameer A Parikh, Sara J Achenbach, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2020
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
Mansi Arora, James M Bogenberger, Amro Abdelrahman, et al.
American Journal of Hematology
|
December 3, 2019
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
Paul J Hampel, Timothy G Call, Wei Ding, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 144) with videos related to
Sort By:
Page
of 15
Leukemia
|
February 16, 2022
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
Nicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, et al.
Annals of Hematology
|
April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients
Verónica González-Calle, Abigail Slack, Niamh Keane, et al.
Blood Cancer Journal
|
February 5, 2025
Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
Rodrigo Fonseca, Yuan Xiao Zhu, Laura A Bruins, et al.
Blood
|
July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes
K Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Cancers
|
July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations
J Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Leukemia
|
March 16, 2019
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Blood
|
August 15, 2022
Progression and survival of MBL: a screening study of 10 139 individuals
Susan L Slager, Sameer A Parikh, Sara J Achenbach, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2020
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
Mansi Arora, James M Bogenberger, Amro Abdelrahman, et al.
American Journal of Hematology
|
December 3, 2019
Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
Paul J Hampel, Timothy G Call, Wei Ding, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Page
of 15